Prescriber's Corner

Eribulin Mesylate: Unique Advancement in Metastatic Breast Cancer

Kelley D. Mayden, MSN, FNP, AOCNP®

From Southwest Virginia Cancer Center, Norton, Virginia

The author has no conflicts of interest to disclose.

Correspondence to: Kelley D. Mayden, MSN, FNP, AOCNP®, 671 Highway 58 East, Norton, VA 24273. E-mail: kdunrun@charter.net


J Adv Pract Oncol 2011;2:125–128 | DOI: 10.6004/jadpro.2011.2.2.7 | © 2011 Harborside Press®


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.